These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1429602)

  • 21. Incorporation of structurally defective type II collagen into cartilage matrix in kniest chondrodysplasia.
    Fernandes RJ; Wilkin DJ; Weis MA; Wilcox WR; Cohn DH; Rimoin DL; Eyre DR
    Arch Biochem Biophys; 1998 Jul; 355(2):282-90. PubMed ID: 9675039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incorporation of type I collagen molecules that contain a mutant alpha 2(I) chain (Gly580-->Asp) into bone matrix in a lethal case of osteogenesis imperfecta.
    Niyibizi C; Bonadio J; Byers PH; Eyre DR
    J Biol Chem; 1992 Nov; 267(32):23108-12. PubMed ID: 1385413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A de novo G to T transversion in a pro-alpha 1 (I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain.
    Valli M; Mottes M; Tenni R; Sangalli A; Gomez Lira M; Rossi A; Antoniazzi F; Cetta G; Pignatti PF
    J Biol Chem; 1991 Jan; 266(3):1872-8. PubMed ID: 1988452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A COL2A1 mutation in achondrogenesis type II results in the replacement of type II collagen by type I and III collagens in cartilage.
    Chan D; Cole WG; Chow CW; Mundlos S; Bateman JF
    J Biol Chem; 1995 Jan; 270(4):1747-53. PubMed ID: 7829510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Osteochondrodysplasia determined genetically by a collagen type II gene mutation].
    Czarny-Ratajczak M; Rogala P; Wolnik-Brzozowska D; Latos-Bieleńska A
    Chir Narzadow Ruchu Ortop Pol; 2001; 66(1):79-86. PubMed ID: 11481990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical features of spondyloepiphyseal dysplasia congenita resulting from the substitution of glycine 997 by serine in the alpha 1(II) chain of type II collagen.
    Cole WG; Hall RK; Rogers JG
    J Med Genet; 1993 Jan; 30(1):27-35. PubMed ID: 8423604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent substitutions of arginine 789 by cysteine in pro-alpha 1 (II) collagen chains produce spondyloepiphyseal dysplasia congenita.
    Chan D; Rogers JF; Bateman JF; Cole WG
    J Rheumatol Suppl; 1995 Feb; 43():37-8. PubMed ID: 7752132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The deletion of six amino acids at the C-terminus of the alpha 1 (II) chain causes overmodification of type II and type XI collagen: further evidence for the association between small deletions in COL2A1 and Kniest dysplasia.
    Winterpacht A; Superti-Furga A; Schwarze U; Stöss H; Steinmann B; Spranger J; Zabel B
    J Med Genet; 1996 Aug; 33(8):649-54. PubMed ID: 8863156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substitution of arginine for glycine 664 in the collagen alpha 1(I) chain in lethal perinatal osteogenesis imperfecta. Demonstration of the peptide defect by in vitro expression of the mutant cDNA.
    Bateman JF; Lamande SR; Dahl HH; Chan D; Cole WG
    J Biol Chem; 1988 Aug; 263(24):11627-30. PubMed ID: 3403550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cartilage collagen analysis in the chondrodystrophies.
    Horton WA; Chou JW; Machado MA
    Coll Relat Res; 1985 Sep; 5(4):349-54. PubMed ID: 4053564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type II collagen defect in two sibs with the Goldblatt syndrome, a chondrodysplasia with dentinogenesis imperfecta, and joint laxity.
    Bonaventure J; Stanescu R; Stanescu V; Allain JC; Muriel MP; Ginisty D; Maroteaux P
    Am J Med Genet; 1992 Dec; 44(6):738-53. PubMed ID: 1481841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substitution of cysteine for glycine within the carboxyl-terminal telopeptide of the alpha 1 chain of type I collagen produces mild osteogenesis imperfecta.
    Cohn DH; Apone S; Eyre DR; Starman BJ; Andreassen P; Charbonneau H; Nicholls AC; Pope FM; Byers PH
    J Biol Chem; 1988 Oct; 263(29):14605-7. PubMed ID: 3170557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The type II collagenopathies: a spectrum of chondrodysplasias.
    Spranger J; Winterpacht A; Zabel B
    Eur J Pediatr; 1994 Feb; 153(2):56-65. PubMed ID: 8157027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Widely distributed mutations in the COL2A1 gene produce achondrogenesis type II/hypochondrogenesis.
    Körkkö J; Cohn DH; Ala-Kokko L; Krakow D; Prockop DJ
    Am J Med Genet; 2000 May; 92(2):95-100. PubMed ID: 10797431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Achondrogenesis II-hypochondrogenesis: variability versus heterogeneity.
    Borochowitz Z; Ornoy A; Lachman R; Rimoin DL
    Am J Med Genet; 1986 Jun; 24(2):273-88. PubMed ID: 3717210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serine for glycine substitutions in type I collagen in two cases of type IV osteogenesis imperfecta (OI). Additional evidence for a regional model of OI pathophysiology.
    Marini JC; Lewis MB; Wang Q; Chen KJ; Orrison BM
    J Biol Chem; 1993 Feb; 268(4):2667-73. PubMed ID: 8094076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of type II and type XI collagen synthesis by an immortalized rat chondrocyte cell line (IRC) having a low level of type II collagen mRNA expression.
    Oxford JT; Doege KJ; Horton WE; Morris NP
    Exp Cell Res; 1994 Jul; 213(1):28-36. PubMed ID: 8020600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cartilage expression of a type II collagen mutation in an inherited form of osteoarthritis associated with a mild chondrodysplasia.
    Eyre DR; Weis MA; Moskowitz RW
    J Clin Invest; 1991 Jan; 87(1):357-61. PubMed ID: 1985108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spondyloepiphyseal dysplasia congenita caused by double heterozygous mutations in COL2A1.
    Kawano O; Nakamura A; Morikawa S; Uetake K; Ishizu K; Tajima T
    Am J Med Genet A; 2015 Jul; 167(7):1578-81. PubMed ID: 25900302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Y-position collagen II mutation disrupts cartilage formation and skeletal development in a transgenic mouse model of spondyloepiphyseal dysplasia.
    Gaiser KG; Maddox BK; Bann JG; Boswell BA; Keene DR; Garofalo S; Horton WA
    J Bone Miner Res; 2002 Jan; 17(1):39-47. PubMed ID: 11771668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.